echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Huang Guo investigates the progress of new crown vaccine drug research and development in Beijing

    Huang Guo investigates the progress of new crown vaccine drug research and development in Beijing

    • Last Update: 2023-02-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    ntenteditable="false" style="border-top:1px dashed rgb(255, 0, 0); color:rgb(255, 255, 255); display:block; font-size:0px; height:0px; left:20px; line-height:0px; margin:0px; padding:0px; position:absolute; top:165px; user-select:none; width:703px; z-index:9999">ntenteditable="false" style="-webkit-border-radius:2px; background:url( center no-repeat #ff0000; border-radius:2px; color:#fff; cursor:pointer; display:block; font-size:0px; height:17px; line-height:0px; margin:0px; padding:0px; position:absolute; right:17px; top:-8px; width:17px; z-index:9999" title="Insert paragraph here">↵  On January 11, Huang Guo, Deputy Director of the State Food and Drug Administration, led a team to Sinopharm China Biotechnology Co.
    , Ltd.
    to investigate the progress of the research and development of
    new crown vaccines and related drugs.
    Huang Guo stressed that China's epidemic prevention and control has entered a new stage, the research and development of new crown vaccine drugs should be accelerated, and the quality and safety assurance work should not be relaxed, and the State Food and Drug Administration will continue to maintain a wartime state, with the attitude of starting from scratch and starting again, coordinating supervision and services, and fully serving "health protection" and "prevention of severe disease"
    .
    Huang Guo and his entourage had an in-depth understanding of the company's new crown vaccine informatization traceability, learned about the progress of the research and development of new crown virus multivalent vaccine and related drugs, discussed the problems and difficulties they faced, and gave guidance
    .
    Huang Guo pointed out that vaccines and drugs provide a basic guarantee for epidemic prevention and control, and the State Food and Drug Administration will carefully and consistently serve to ensure the overall situation of epidemic prevention and control, adopt the method of early intervention, research and review linkage, and scientifically and rigorously promote the development and marketing of relevant vaccine drugs in accordance with laws and regulations
    .
    Enterprises should focus on the needs of epidemic prevention and control, further optimize R&D strategies, carry out research in a scientific and standardized manner, increase R&D research efforts, and improve key technology levels
    .
    At the same time, it is necessary to improve the accessibility of drugs and meet the needs
    of the people.
    Relevant responsible comrades of the Drug Registration Department of the State Food and Drug Administration and the Drug Review Center participated in the investigation
    .
    ={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"share:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
    appendChild(createElement('script')).
    src='http://bdimg.
    share.
    baidu.
    com/static/api/js/share.
    js?v=89860593.
    js?cdnversion='+~(-new Date()/36e5)];
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.